{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T11:14:28Z","timestamp":1789470868161,"version":"build-2803163510"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T00:00:00Z","timestamp":1551225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"UK MPS Society"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.omtm.2019.02.007","type":"journal-article","created":{"date-parts":[[2019,3,2]],"date-time":"2019-03-02T00:04:53Z","timestamp":1551485093000},"page":"321-333","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Strategies for the Induction of Immune Tolerance to Enzyme Replacement Therapy in Mucopolysaccharidosis Type I"],"prefix":"10.1016","volume":"13","author":[{"given":"Arunabha","family":"Ghosh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiyin","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"O\u2019Leary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Mercer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Tylee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anu","family":"Goenka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Holley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon A.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian W.","family":"Bigger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2019.02.007_bib1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1542\/peds.2008-0416","article-title":"Mucopolysaccharidosis I: management and treatment guidelines","volume":"123","author":"Muenzer","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.omtm.2019.02.007_bib2","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1750-1172-6-55","article-title":"Enzyme replacement therapy and\/or hematopoietic stem cell transplantation at diagnosis in patients with mucopolysaccharidosis type I: results of a European consensus procedure","volume":"6","author":"de Ru","year":"2011","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.omtm.2019.02.007_bib3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jpeds.2008.07.004","article-title":"Use of enzyme replacement therapy (Laronidase) before hematopoietic stem cell transplantation for mucopolysaccharidosis I: experience in 18 patients","volume":"154","author":"Wynn","year":"2009","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.omtm.2019.02.007_bib4","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10545-012-9500-3","article-title":"Management of mucopolysaccharidosis type IH (Hurler\u2019s syndrome) presenting in infancy with severe dilated cardiomyopathy: a single institution\u2019s experience","volume":"36","author":"Wiseman","year":"2013","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.omtm.2019.02.007_bib5","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ymgme.2016.01.011","article-title":"Enzyme replacement therapy prior to haematopoietic stem cell transplantation in Mucopolysaccharidosis Type I: 10 year combined experience of 2 centres","volume":"117","author":"Ghosh","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.omtm.2019.02.007_bib6","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ymgme.2015.11.001","article-title":"Immune response to enzyme replacement therapies in lysosomal storage diseases and the role of immune tolerance induction","volume":"117","author":"Kishnani","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.omtm.2019.02.007_bib7","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s10545-016-9917-1","article-title":"The impact of the immune system on the safety and efficiency of enzyme replacement therapy in lysosomal storage disorders","volume":"39","author":"Broomfield","year":"2016","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.omtm.2019.02.007_bib8","first-page":"2868","article-title":"Immune tolerance improves the efficacy of enzyme replacement therapy in canine mucopolysaccharidosis I","volume":"118","author":"Dickson","year":"2008","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtm.2019.02.007_bib9","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ymgme.2012.02.003","article-title":"Specific antibody titer alters the effectiveness of intrathecal enzyme replacement therapy in canine mucopolysaccharidosis I","volume":"106","author":"Dickson","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.omtm.2019.02.007_bib10","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ymgme.2014.10.012","article-title":"Biomarker responses correlate with antibody status in mucopolysaccharidosis type I patients on long-term enzyme replacement therapy","volume":"114","author":"Langereis","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.omtm.2019.02.007_bib11","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.3324\/haematol.2011.058644","article-title":"Hematopoietic stem cell transplantation improves the high incidence of neutralizing allo-antibodies observed in Hurler\u2019s syndrome after pharmacological enzyme replacement therapy","volume":"97","author":"Saif","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.omtm.2019.02.007_bib12","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13023-015-0255-4","article-title":"Sleep disordered breathing in mucopolysaccharidosis I: a multivariate analysis of patient, therapeutic and metabolic correlators modifying long term clinical outcome","volume":"10","author":"Pal","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.omtm.2019.02.007_bib13","first-page":"219","article-title":"Outcomes of Long-Term Treatment with Laronidase in Patients with Mucopolysaccharidosis Type","volume":"178","author":"Laraway","year":"2016","journal-title":"I.\u00a0J. Pediatr."},{"key":"10.1016\/j.omtm.2019.02.007_bib14","first-page":"61","article-title":"Immune tolerance induction for laronidase treatment in mucopolysaccharidosis I","volume":"10","author":"Giugliani","year":"2017","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.omtm.2019.02.007_bib15","doi-asserted-by":"crossref","first-page":"e67052","DOI":"10.1371\/journal.pone.0067052","article-title":"Algorithm for the early diagnosis and treatment of patients with cross reactive immunologic material-negative classic infantile pompe disease: a step towards improving the efficacy of ERT","volume":"8","author":"Banugaria","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtm.2019.02.007_bib16","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s10545-015-9898-5","article-title":"Response of 33\u00a0UK patients with infantile-onset Pompe disease to enzyme replacement therapy","volume":"39","author":"Broomfield","year":"2016","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.omtm.2019.02.007_bib17","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/GIM.0b013e3182174703","article-title":"The impact of antibodies on clinical outcomes in diseases treated with therapeutic protein: lessons learned from infantile Pompe disease","volume":"13","author":"Banugaria","year":"2011","journal-title":"Genet. Med."},{"key":"10.1016\/j.omtm.2019.02.007_bib18","first-page":"168","article-title":"Understanding the mechanisms of action of methotrexate: implications for the treatment of rheumatoid arthritis","volume":"65","author":"Tian","year":"2007","journal-title":"Bull. NYU Hosp. Jt. Dis."},{"key":"10.1016\/j.omtm.2019.02.007_bib19","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.4049\/jimmunol.1303326","article-title":"Transient low-dose methotrexate generates B regulatory cells that mediate antigen-specific tolerance to alglucosidase alfa","volume":"193","author":"Joly","year":"2014","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.omtm.2019.02.007_bib20","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1365-2249.2008.03602.x","article-title":"Immune tolerance induction to enzyme-replacement therapy by co-administration of short-term, low-dose methotrexate in a murine Pompe disease model","volume":"152","author":"Joseph","year":"2008","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.omtm.2019.02.007_bib21","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/j.ymgme.2015.12.315","article-title":"Prophylactic immune modulation in infantile Pompe disease using low-dose methotrexate induction: A safe, inexpensive, widely accessible, and efficacious strategy","volume":"117","author":"Kazi","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.omtm.2019.02.007_bib22","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/j.ymgme.2017.12.080","article-title":"An immune tolerance approach using methotrexate in the na\u00efve setting of patients treated with a therapeutic protein: Experience in infantile Pompe disease","volume":"123","author":"Desai","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.omtm.2019.02.007_bib23","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/gene.2014.45","article-title":"Regulatory T\u00a0cells and immune regulation of allergic diseases: roles of IL-10 and TGF-\u03b2","volume":"15","author":"Palomares","year":"2014","journal-title":"Genes Immun."},{"key":"10.1016\/j.omtm.2019.02.007_bib24","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.0105-2896.2006.00406.x","article-title":"Infectious tolerance and the long-term acceptance of transplanted tissue","volume":"212","author":"Waldmann","year":"2006","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.omtm.2019.02.007_bib25","doi-asserted-by":"crossref","first-page":"e77632","DOI":"10.1371\/journal.pone.0077632","article-title":"Signal one and two blockade are both critical for non-myeloablative murine HSCT across a major histocompatibility complex barrier","volume":"8","author":"Langford-Smith","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtm.2019.02.007_bib26","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1073\/pnas.0305480101","article-title":"Successful induction of immune tolerance to enzyme replacement therapy in canine mucopolysaccharidosis I","volume":"101","author":"Kakkis","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2019.02.007_bib27","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ymgme.2009.08.003","article-title":"Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants","volume":"99","author":"Kishnani","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.omtm.2019.02.007_bib28","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1542\/peds.2006-2156","article-title":"Enzyme replacement therapy in patients who have mucopolysaccharidosis I and are younger than 5 years: results of a multinational study of recombinant human alpha-L-iduronidase (laronidase)","volume":"120","author":"Wraith","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.omtm.2019.02.007_bib29","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s10038-008-0272-4","article-title":"Structural study on mutant alpha-L-iduronidases: insight into mucopolysaccharidosis type I","volume":"53","author":"Sugawara","year":"2008","journal-title":"J.\u00a0Hum. Genet."},{"key":"10.1016\/j.omtm.2019.02.007_bib30","first-page":"425","article-title":"Mucopolysaccharidosis type I: Identification and characterization of mutations affecting alpha-L-iduronidase activity","volume":"101","author":"Lee-Chen","year":"2002","journal-title":"J.\u00a0Formos. Med. Assoc."},{"key":"10.1016\/j.omtm.2019.02.007_bib31","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ymgme.2013.05.016","article-title":"Residual \u03b1-L-iduronidase activity in fibroblasts of mild to severe Mucopolysaccharidosis type I patients","volume":"109","author":"Oussoren","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.omtm.2019.02.007_bib32","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/GIM.0b013e3181fea459","article-title":"Long-term, open-labeled extension study of idursulfase in the treatment of Hunter syndrome","volume":"13","author":"Muenzer","year":"2011","journal-title":"Genet. Med."},{"key":"10.1016\/j.omtm.2019.02.007_bib33","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s10545-011-9369-6","article-title":"Longitudinal observations of serum heparin cofactor II-thrombin complex in treated Mucopolysaccharidosis I and II patients","volume":"35","author":"Clarke","year":"2012","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.omtm.2019.02.007_bib34","first-page":"S72","article-title":"Management guidelines for infantile onset lysosomal acid lipase deficiency (LALD)","volume":"123","author":"Jones","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.omtm.2019.02.007_bib35","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/eji.1830201231","article-title":"Induction of tolerance in peripheral T\u00a0cells with monoclonal antibodies","volume":"20","author":"Qin","year":"1990","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.omtm.2019.02.007_bib36","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1046\/j.1365-2141.2002.03666.x","article-title":"Use of a non-depleting anti-CD4 antibody to modulate the immune response to coagulation factors VIII and IX","volume":"118","author":"Salooja","year":"2002","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.omtm.2019.02.007_bib37","first-page":"446","article-title":"Non-depleting anti-CD4 monoclonal antibody induces immune tolerance to ERT in a murine model of Pompe disease","volume":"1","author":"Sun","year":"2014","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.omtm.2019.02.007_bib38","doi-asserted-by":"crossref","first-page":"6003","DOI":"10.4049\/jimmunol.172.10.6003","article-title":"Induction of foxP3+ Regulatory T Cells in the Periphery of T Cell Receptor Transgenic Mice Tolerized to Transplants","volume":"172","author":"Cobbold","year":"2004","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.omtm.2019.02.007_bib39","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1084\/jem.20110767","article-title":"Sustained suppression by Foxp3+ regulatory T\u00a0cells is vital for infectious transplantation tolerance","volume":"208","author":"Kendal","year":"2011","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.omtm.2019.02.007_bib40","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jaut.2013.08.008","article-title":"CD4 blockade directly inhibits mouse and human CD4(+) T\u00a0cell functions independent of Foxp3(+) Tregs","volume":"47","author":"Mayer","year":"2013","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.omtm.2019.02.007_bib41","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jaut.2013.08.010","article-title":"Anti-CD4 treatment inhibits autoimmunity in scurfy mice through the attenuation of co-stimulatory signals","volume":"50","author":"Mayer","year":"2014","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.omtm.2019.02.007_bib42","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/intimm\/dxp005","article-title":"Differential control of allo-antigen-specific regulatory T\u00a0cells and effector T\u00a0cells by anti-CD4 and other agents in establishing transplantation tolerance","volume":"21","author":"Nagahama","year":"2009","journal-title":"Int. Immunol."},{"key":"10.1016\/j.omtm.2019.02.007_bib43","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.4049\/jimmunol.174.6.3290","article-title":"The generation of CD25+ CD4+ regulatory T\u00a0cells that prevent allograft rejection does not compromise immunity to a viral pathogen","volume":"174","author":"Bushell","year":"2005","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.omtm.2019.02.007_bib44","doi-asserted-by":"crossref","first-page":"e10558","DOI":"10.1371\/journal.pone.0010558","article-title":"Modulation of IL-17 and Foxp3 expression in the prevention of autoimmune arthritis in mice","volume":"5","author":"Duarte","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtm.2019.02.007_bib45","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3389\/fimmu.2016.00011","article-title":"Tregalizumab - A Monoclonal Antibody to Target Regulatory T Cells","volume":"7","author":"K\u00f6nig","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtm.2019.02.007_bib46","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10928-014-9354-4","article-title":"Physiologically based pharmacokinetic modelling of methotrexate and 6-mercaptopurine in adults and children. Part 1: methotrexate","volume":"41","author":"Ogungbenro","year":"2014","journal-title":"J.\u00a0Pharmacokinet. Pharmacodyn."},{"key":"10.1016\/j.omtm.2019.02.007_bib48","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0140-6736(79)90197-1","article-title":"Prenatal diagnosis of two Hurler fetuses using an improved assay for methylumbelliferyl-alpha-L-iduronidase","volume":"2","author":"Stirling","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/j.omtm.2019.02.007_bib49","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/clinchem\/35.7.1472","article-title":"Dimethylmethylene blue-based spectrophotometry of glycosaminoglycans in untreated urine: a rapid screening procedure for mucopolysaccharidoses","volume":"35","author":"de Jong","year":"1989","journal-title":"Clin. Chem."},{"key":"10.1016\/j.omtm.2019.02.007_bib50","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/S0140-6736(73)90560-6","article-title":"Prenatal diagnosis of mucopolysaccharidoses","volume":"1","author":"Whiteman","year":"1973","journal-title":"Lancet"},{"key":"10.1016\/j.omtm.2019.02.007_bib51","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/sj.bmt.1705569","article-title":"Biochemical monitoring after haemopoietic stem cell transplant for Hurler syndrome (MPSIH): implications for functional outcome after transplant in metabolic disease","volume":"39","author":"Church","year":"2007","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.omtm.2019.02.007_bib52","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s10545-012-9538-2","article-title":"Plasma and urinary levels of dermatan sulfate and heparan sulfate derived disaccharides after long-term enzyme replacement therapy (ERT) in MPS I: correlation with the timing of ERT and with total urinary excretion of glycosaminoglycans","volume":"36","author":"de Ru","year":"2013","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.omtm.2019.02.007_bib53","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.4049\/jimmunol.163.9.4805","article-title":"CD40 ligand blockade induces CD4+ T\u00a0cell tolerance and linked suppression","volume":"163","author":"Honey","year":"1999","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.omtm.2019.02.007_bib54","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/hmg\/6.4.503","article-title":"Murine mucopolysaccharidosis type I: targeted disruption of the murine \u03b1-L-iduronidase gene","volume":"6","author":"Clarke","year":"1997","journal-title":"Hum. Mol. Genet."}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050119300245?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050119300245?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:25:00Z","timestamp":1762421100000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050119300245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":53,"alternative-id":["S2329050119300245"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2019.02.007","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Strategies for the Induction of Immune Tolerance to Enzyme Replacement Therapy in Mucopolysaccharidosis Type I","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2019.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2019","name":"copyright","label":"Copyright"}]}}